SCHEMBL30002129

SCHEMBL30002129

CC(C)(C)OC(=O)N1CC[C@H](C(=O)NCc2ccc(OCc3ccc(Cl)cc3)cc2)C1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPK8 P45983 1/20 0.52
ALDH1A1 P00352 2/20 0.51
LMNA P02545 2/20 0.51
STS P08842 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.49
HTT P42858 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
YAP1 P46937 2/20 0.49
EPHX2 P34913 2/20 0.49
RAB9A P51151 2/20 0.49
NPC1 O15118 1/20 0.49
POLB P06746 1/20 0.49
SLC13A5 Q86YT5 1/20 0.48
GAA P10253 1/20 0.47
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA9 Q16790 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL654138 0.92 MAPK8 (0.58) MAPK8ALDH1A1LMNASTSSMN1; SMN2
SCHEMBL20111126 0.91 YAP1 (0.58) MAPK8ALDH1A1LMNASTSSMN1; SMN2
SCHEMBL30001636 0.89 TACR1 (0.54) MAPK8ALDH1A1LMNASTSSMN1; SMN2
SCHEMBL171943 0.87 STS (0.64) ALDH1A1LMNASTSSMN1; SMN2HTT
SCHEMBL30001634 0.85 GPR119 (0.52) ALDH1A1LMNAYAP1EPHX2
SCHEMBL30002303 0.83 SLC6A5 (0.53) ALDH1A1EPHX2RAB9ANPC1POLB
SCHEMBL30879864 0.82 NPSR1 (0.64) MAPK8ALDH1A1LMNASTSNPSR1
SCHEMBL27309928 0.82 NPSR1 (0.64) MAPK8ALDH1A1LMNASTSNPSR1
SCHEMBL30002020 0.81 ALDH1A1 (0.65) ALDH1A1LMNASMN1; SMN2NPSR1NPC1
SCHEMBL27022355 0.80 ALDH1A1 (0.71) ALDH1A1LMNASTSSMN1; SMN2EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250205195-A1 BENZYLOXY-BENZYLAMINYL AMINO ACID DERIVATIVE FOR ADJUSTING TSLP/TSLPR SIGNAL TRANSMISSION AMTIXBIO CO., LTD. (KR) 2025-06-26 US claimed
US-20250205195-A1 BENZYLOXY-BENZYLAMINYL AMINO ACID DERIVATIVE FOR ADJUSTING TSLP/TSLPR SIGNAL TRANSMISSION AMTIXBIO CO., LTD. (KR) 2025-06-26 US disclosed
US-20250034083-A1 METHODS FOR PREPARING BENZYLOXYBENZYLAMINE AMINO ACID DERIVATIVES AMTIXBIO CO., LTD. (KR) 2025-01-30 US disclosed
WO-2022255801-A1 BENZYLOXY-BENZYLAMINYL AMINO ACID DERIVATIVE FOR ADJUSTING TSLP/TSLPR SIGNAL TRANSMISSION (주)앰틱스바이오 2022-12-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250034083-A1 METHODS FOR PREPARING BENZYLOXYBENZYLAMINE AMINO ACID DERIVATIVES BCAT2, BCAT1, DAO MAPK8 3692/4885ALDH1A1 3211/4885LMNA 3430/4885
US-20250205195-A1 BENZYLOXY-BENZYLAMINYL AMINO ACID DERIVATIVE FOR ADJUSTING TSLP/TSLPR SIGNAL TRANSMISSION TSLP, IL2RA, TRPC7 MAPK8 616/4885ALDH1A1 4354/4885LMNA 4019/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.